CTOs on the Move

Promentis Pharmaceuticals

www.promentispharma.com

 
Promentis Pharmaceuticals, Inc., is a privately held biopharmaceutical company focused on the discovery and development of first-in-class therapies to treat central nervous system (CNS) disorders. Promentis` drug development program is focused on activating a unique target known to restore glutamatergic neurotransmission and imbalances in oxidative stress, key contributors to impaired cortical function linked to multiple CNS disorders. The Company`s lead compound, SXC-2023, is being developed to treat various psychiatric disorders, with an initial focus on an indication that, despite representing a common disorder affecting millions of patients, has no FDA-approved treatment and a high level of patient need.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Promentis Pharmaceuticals raised $26M on 03/30/2017

Similar Companies

Leiters

Leiters is a FDA-registered 503B outsourcing provider of high quality ophthalmology and hospital-based services. We are committed to providing healthcare professionals and their patients with high quality medications.

Curium Pharma

Risas Dental and Braces

Affordable dental and orthodontics for the whole family by top doctors! Open Mon-Sat 9am-8pm. 24 locations in Arizona, Colorado, Nevada, and Texas

AccuMed

AccuMed Inc. is a Lawrence Township, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BigHat Biosciences

BigHat`s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics.